SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors rally behind better-than-expected cloud growth and AI demand, which successfully eased concerns about excessive capital expenditure. Community discussions are centered on the company's ability to maintain FCF positivity and long-term enterprise adoption, with many investors viewing the positive earnings as a vital stabilizing force for the broader tech sector.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the unexpected announcement of broad marketing authorization for Anktiva in the UAE, a development the community sees as a significant validation of the drug's global market potential. Investors are actively discussing this regulatory win as a catalyst for future revenue growth, while simultaneously tracking commercial progress and preparing for upcoming quarterly results.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure after a profit miss and a surge in capital expenditures caused investors to question the return on the company's aggressive AI infrastructure spending. While the community remains divided over the firm's long-term profitability, active discussions center on whether this represents a temporary valuation reset or a more permanent shift in market sentiment toward AI-heavy spending cycles.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market participants are actively debating the potential for an oversold bounce as the Invesco QQQ Trust experiences significant volatility fueled by fears over AI sector capital expenditure and geopolitical tensions. Community sentiment is deeply polarized, with many traders analyzing historical tech cycles and bond market signals to gauge whether current price action represents a capitulation or the beginning of a prolonged downward correction.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF is trending as investors grapple with shifting rate hike expectations and heightened geopolitical uncertainty in the Middle East, leading to significant volatility in bond yields. Community discourse is heavily focused on the bond market acting as a barometer for broader economic stress, with traders debating whether persistent inflation and geopolitical risks will continue to pressure long-duration assets.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing extreme volatility as investors navigate a broader semiconductor selloff, with community sentiment caught between concerns over a shifting AI spending narrative and bullish views that current valuation levels present a significant buying opportunity. The stock remains heavily influenced by global macro correlations, particularly with Korean tech indices and leveraged liquidity events, keeping traders focused on the sustainability of long-term AI-driven memory demand.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor interest ahead of earnings as the market monitors its consistent execution of large, upsized ABS deals and institutional credit growth. Community members are actively debating the stock's resilience against broader fintech sector volatility and geopolitical macro pressures while focusing on potential upside from its AI-driven underwriting model.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is under increased market scrutiny as investors weigh aggressive AI infrastructure spending against broader concerns about cloud-revenue growth and profitability. The community is actively debating the stock's long-term potential ahead of key earnings, with many focusing on whether management can justify its massive capital expenditure while navigating a volatile macro environment.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is currently facing significant volatility as investors weigh the potential for a transformative obesity drug readout in the coming months against management's cautious communication style and ongoing insider selling. The community remains deeply divided between long-term bulls anticipating a high-value partnership or acquisition and skeptical shorts who are capitalizing on the stock's recent cooling and broader biotech sector pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
